Kalaris Therapeutics, Inc. (KLRS)

CIK 1754068 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Kalaris Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 28, 202640001193125-26-374352
Aug 11, 20268-K0001193125-26-343477
Aug 11, 202610-Q0001193125-26-344532
Aug 3, 202640001193125-26-330530
Aug 3, 202630001193125-26-330516
Jul 27, 202630001193125-26-318054
Jul 20, 20268-K0001193125-26-308382
Jul 20, 202630001193125-26-309027
Jul 20, 202640001193125-26-309047
Jul 17, 20268-K0001193125-26-306737
Jul 6, 20268-K0001193125-26-296190
Jun 4, 202640001193125-26-257445
Jun 4, 202640001193125-26-257471
Jun 4, 202640001193125-26-257556
Jun 4, 202640001193125-26-257494
Jun 4, 202640001193125-26-257465
Jun 4, 202640001193125-26-257564
Jun 4, 202640001193125-26-257462
Jun 4, 20268-K0001193125-26-257388
May 22, 2026SCHEDULE 13D/A0001699737-26-000012
May 22, 202640001231919-26-000532
May 12, 20268-K0001193125-26-218240
May 12, 202610-Q0001193125-26-219328
Apr 24, 2026ARS0001193125-26-177387
Apr 24, 2026DEF 14A0001193125-26-177362